These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35351534)

  • 1. White Coat Hypertension Persistence in Children and Adolescents: The Pediatric Nephrology Research Consortium Study.
    Miyashita Y; Hanevold C; Faino A; Scher J; Lande M; Yamaguchi I; Hernandez J; Acosta A; Weaver DJ; Thomas J; Kallash M; Ferguson M; Patel KN; South AM; Kelton M; Flynn JT
    J Pediatr; 2022 Jul; 246():154-160.e1. PubMed ID: 35351534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Office blood pressure versus ambulatory blood pressure measurement in childhood obesity.
    van der Heijden LB; Groothoff JW; Feskens EJ; Janse AJ
    BMC Pediatr; 2023 Apr; 23(1):205. PubMed ID: 37120521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Ambulatory Blood Pressure Phenotype over Time in Children and Adolescents with Elevated Blood Pressures.
    Hanevold CD; Miyashita Y; Faino AV; Flynn JT
    J Pediatr; 2020 Jan; 216():37-43.e2. PubMed ID: 31685228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.
    Muxfeldt ES; Fiszman R; de Souza F; Viegas B; Oliveira FC; Salles GF
    Hypertension; 2012 Feb; 59(2):384-9. PubMed ID: 22215711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of ambulatory blood pressure monitoring in the evaluation of elevated clinic blood pressures in children.
    Halbach SM; Hamman R; Yonekawa K; Hanevold C
    J Am Soc Hypertens; 2016 May; 10(5):406-12. PubMed ID: 27026571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Pressure Classification Status in Children With CKD Following Adoption of the 2017 American Academy of Pediatrics Guideline.
    Ng DK; Carroll MK; Furth SL; Warady BA; Flynn JT;
    Am J Kidney Dis; 2023 May; 81(5):545-553. PubMed ID: 36521780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Utility of 24-Hour Ambulatory Blood Pressure Monitoring to Distinguish Pediatric Populations Presenting with Elevated Blood Pressure in Rhode Island.
    Kurland J; Carillo M; Cordero FJ; Kremsdorf R; Faizan MK
    R I Med J (2013); 2024 Feb; 107(2):30-35. PubMed ID: 38285750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reclassification of adolescent hypertension by ambulatory blood pressure monitoring using adult norms and association with left ventricular hypertrophy.
    Campbell JF; Shah S; Srivaths P; Acosta AA
    J Clin Hypertens (Greenwich); 2021 Feb; 23(2):265-271. PubMed ID: 33421283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of white-coat hypertension in children and adolescents: A Midwest Pediatric Nephrology Consortium study.
    Miyashita Y; Flynn JT; Hanevold CD
    J Clin Hypertens (Greenwich); 2017 Sep; 19(9):884-889. PubMed ID: 28736962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals.
    Johnson PK; Ferguson MA; Zachariah JP
    Congenit Heart Dis; 2016 Jul; 11(4):309-14. PubMed ID: 27205889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ambulatory blood pressure monitoring on the diagnosis of hypertension in children.
    Lubrano R; Paoli S; Spiga S; Falsaperla R; Vitaliti G; Gentile I; Elli M
    J Am Soc Hypertens; 2015 Oct; 9(10):780-784. PubMed ID: 26345259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA; Hatzigeorgiou C
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence and determinants of blood pressure phenotypes according to office and ambulatory blood pressure measurements in youth.
    Martinez F; Redon J; Aguilar F; Calderon JM; Lurbe E
    Hypertens Res; 2023 May; 46(5):1257-1266. PubMed ID: 36635525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure patterns in children with chronic kidney disease.
    Samuels J; Ng D; Flynn JT; Mitsnefes M; Poffenbarger T; Warady BA; Furth S;
    Hypertension; 2012 Jul; 60(1):43-50. PubMed ID: 22585950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of ambulatory BP monitoring in pediatric nephrology?
    Gavrilovici C; Goldsmith DJ; Reid C; Gubeth-Tatomir P; Covic A
    J Nephrol; 2004; 17(5):642-52. PubMed ID: 15593030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory Blood Pressure Monitoring in Pediatrics, an Update on Interpretation and Classification of Hypertension Phenotypes.
    Basalely A; Hill-Horowitz T; Sethna CB
    Curr Hypertens Rep; 2023 Jan; 25(1):1-11. PubMed ID: 36434426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reclassification of Adolescent Ambulatory Prehypertension and Unclassified Blood Pressures by 2022 American Heart Association Pediatric Ambulatory Blood Pressure Monitoring Guidelines.
    Hill-Horowitz T; Merchant K; Abdullah M; Castellanos-Reyes L; Singer P; Dukkipati H; Frank R; Sethna CB; Basalely A
    J Pediatr; 2024 Mar; 266():113895. PubMed ID: 38154521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Performance of Office versus Ambulatory Blood Pressure in Kidney Transplant Recipients.
    Korogiannou M; Sarafidis P; Theodorakopoulou MP; Alexandrou ME; Xagas E; Boletis IN; Marinaki S
    Am J Nephrol; 2021; 52(7):548-558. PubMed ID: 34311458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
    Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
    Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.